AVLSA
JBIO
Atlas Venture Life Science Advisors’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,799,232
| Closed | -$4.52M | – | 12 |
|
|
2025
Q1 | $4.52M | Hold |
1,799,232
| – | – | 0.87% | 10 |
|
|
2024
Q4 | $4.77M | Hold |
1,799,232
| – | – | 0.58% | 11 |
|
|
2024
Q3 | $3.76M | Hold |
1,799,232
| – | – | 0.35% | 12 |
|
|
2024
Q2 | $2.99M | Sell |
1,799,232
-240,017
| -12% | -$398K | 0.31% | 14 |
|
|
2024
Q1 | $60.3M | Hold |
2,039,249
| – | – | 5.57% | 7 |
|
|
2023
Q4 | $46.1M | Hold |
2,039,249
| – | – | 5.5% | 7 |
|
|
2023
Q3 | $27.7M | Hold |
2,039,249
| – | – | 4.29% | 9 |
|
|
2023
Q2 | $35M | Hold |
2,039,249
| – | – | 4.35% | 9 |
|
|
2023
Q1 | $41.1M | Buy |
2,039,249
+21,728
| +1% | +$438K | 5.57% | 7 |
|
|
2022
Q4 | $59.1M | Sell |
2,017,521
-310,388
| -13% | -$9.09M | 7.12% | 6 |
|
|
2022
Q3 | $38.6M | Sell |
2,327,909
-310,388
| -12% | -$5.15M | 4.26% | 8 |
|
|
2022
Q2 | $41.2M | Sell |
2,638,297
-465,582
| -15% | -$7.28M | 6.89% | 6 |
|
|
2022
Q1 | $56.9M | Hold |
3,103,879
| – | – | 7.19% | 5 |
|
|
2021
Q4 | $36.6M | Buy |
+3,103,879
| New | +$36.6M | 3.36% | 9 |
|